ATE465713T1 - Stabile zusammensetzungen mit aussenmembranvesikeln sowie herstellungsverfahren - Google Patents

Stabile zusammensetzungen mit aussenmembranvesikeln sowie herstellungsverfahren

Info

Publication number
ATE465713T1
ATE465713T1 AT05761528T AT05761528T ATE465713T1 AT E465713 T1 ATE465713 T1 AT E465713T1 AT 05761528 T AT05761528 T AT 05761528T AT 05761528 T AT05761528 T AT 05761528T AT E465713 T1 ATE465713 T1 AT E465713T1
Authority
AT
Austria
Prior art keywords
outer membrane
production methods
membrane vesicles
stable compositions
compositions
Prior art date
Application number
AT05761528T
Other languages
English (en)
Inventor
Andrew Gorringe
Phillip Vincent
Denise Halliwell
Karen Reddin
Original Assignee
Health Prot Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Prot Agency filed Critical Health Prot Agency
Application granted granted Critical
Publication of ATE465713T1 publication Critical patent/ATE465713T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
AT05761528T 2004-07-19 2005-07-18 Stabile zusammensetzungen mit aussenmembranvesikeln sowie herstellungsverfahren ATE465713T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0416120.4A GB0416120D0 (en) 2004-07-19 2004-07-19 Stable compositions containing OMV's
PCT/GB2005/002817 WO2006008504A1 (en) 2004-07-19 2005-07-18 Stable compositions containing outer membrane vesicles, methods of manufacturing

Publications (1)

Publication Number Publication Date
ATE465713T1 true ATE465713T1 (de) 2010-05-15

Family

ID=32893812

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05761528T ATE465713T1 (de) 2004-07-19 2005-07-18 Stabile zusammensetzungen mit aussenmembranvesikeln sowie herstellungsverfahren

Country Status (9)

Country Link
US (1) US7820185B2 (de)
EP (1) EP1778182B1 (de)
AT (1) ATE465713T1 (de)
AU (1) AU2005263950B2 (de)
BR (1) BRPI0513467A (de)
CA (1) CA2574302A1 (de)
DE (1) DE602005020942D1 (de)
GB (1) GB0416120D0 (de)
WO (1) WO2006008504A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
CN104688687A (zh) * 2009-12-03 2015-06-10 诺华股份有限公司 疫苗佐剂制备中的亲水过滤
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506834B1 (de) 2009-12-03 2016-03-02 Novartis AG Zirkulation von bestandteilen während homogenisierung und der mikrofluidisierung von emulsionen
JP2011163623A (ja) * 2010-02-08 2011-08-25 Osaka Gas Co Ltd スケール防止方法
GB201009676D0 (en) 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process
EP3307890A1 (de) 2015-06-10 2018-04-18 Board of Regents, The University of Texas System Verwendung von exosomen zur behandlung von krankheiten
CA3017586A1 (en) * 2016-03-15 2017-09-21 Codiak Biosciences, Inc. Therapeutic membrane vesicles
CA3062426A1 (en) 2017-05-08 2018-11-15 Flagship Pioneering Innovations V, Inc. Compositions for facilitating membrane fusion and uses thereof
BR112023002872A2 (pt) 2020-08-20 2023-03-14 Inst Finlay De Vacunas Composição de vacina que induz uma resposta imune contra o vírus sars-cov-2, procedimento para obter as omvs, e, uso da composição de vacina

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2023448C1 (ru) 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
NL9002092A (nl) 1990-09-25 1992-04-16 Nederlanden Staat Vaccin, geschikt voor de bestrijding van bordetella pertussis.
EP0624376B1 (de) 1993-05-13 2000-03-15 American Cyanamid Company Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
NO20002828D0 (no) 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
ES2260291T3 (es) * 2000-09-28 2006-11-01 Chiron Corporation Microparticulas para la administracion de acidos nucleicos heterologos.
GB0130123D0 (en) 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
EP1585504A4 (de) * 2002-11-06 2009-07-15 Azaya Therapeutics Inc Proteinstabilisierte liposomale formulierungen pharmazeutischer wirkstoffe

Also Published As

Publication number Publication date
DE602005020942D1 (de) 2010-06-10
AU2005263950A1 (en) 2006-01-26
GB0416120D0 (en) 2004-08-18
US7820185B2 (en) 2010-10-26
EP1778182B1 (de) 2010-04-28
AU2005263950B2 (en) 2010-02-04
CA2574302A1 (en) 2006-01-26
US20090041807A1 (en) 2009-02-12
WO2006008504A1 (en) 2006-01-26
EP1778182A1 (de) 2007-05-02
BRPI0513467A (pt) 2008-05-06

Similar Documents

Publication Publication Date Title
ATE465713T1 (de) Stabile zusammensetzungen mit aussenmembranvesikeln sowie herstellungsverfahren
CA133875S (en) Toy building element
AU324478S (en) Display structure
AU324475S (en) Display structure
AU324479S (en) Display structure
AU310935S (en) Earphones
AU324476S (en) Display structure
AU324473S (en) Display structure
AU308855S (en) Camera
AU324477S (en) Display structure
AR069941A1 (es) Lentes de contacto cosmeticas que tienen un efecto chispeante
AU308856S (en) Camera
AU310937S (en) Camera
AU309687S (en) A portable building
AU321483S (en) Toy vehicle
DOU2010000385U (es) Mejora introducida en un mini-pilar cono morse
AU313287S (en) Camera with microphone
WO2004105860A3 (en) Methods of using nitroxides in conjunction with photosensitizers and sonosensitizers
AU312369S (en) Loudspeaker device
AU312151S (en) Loudspeaker device
AU324480S (en) Display structure
BRMU8602043U (pt) telefone celular com função de aparelho para surdez
AU314065S (en) Ring float
AU308079S (en) Fencing panel
AU306555S (en) Toy

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1778182

Country of ref document: EP

REN Ceased due to non-payment of the annual fee